STING1 and non-small cell lung carcinoma: Meanwhile, recent studies have demonstrated a positive correlation between cGAS-STING activation and improved prognosis in chemotherapy and immunotherapy for various cancer types, including NSCLC, colorectal, cervical, breast, and melanoma cancers.36